France

France

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
1.38 (1.30 - 1.44) 2019 Modelled IHME
1.4 (1.33 - 1.46) 2018 Modelled IHME
1.42 (1.35 - 1.48) 2017 Modelled IHME
1.43 (1.36 - 1.49) 2016 Modelled IHME
1.44 (1.36 - 1.50) 2015 Modelled IHME
1.45 (1.37 - 1.51) 2014 Modelled IHME
1.47 (1.40 - 1.53) 2013 Modelled IHME
1.49 (1.42 - 1.55) 2012 Modelled IHME
1.51 (1.44 - 1.57) 2011 Modelled IHME
1.52 (1.45 - 1.59) 2010 Modelled IHME
1.54 (1.46 - 1.60) 2009 Modelled IHME
1.55 (1.47 - 1.61) 2008 Modelled IHME
1.56 (1.48 - 1.63) 2007 Modelled IHME
1.57 (1.49 - 1.64) 2006 Modelled IHME
1.59 (1.50 - 1.66) 2005 Modelled IHME
1.6 (1.51 - 1.67) 2004 Modelled IHME
1.61 (1.52 - 1.68) 2003 Modelled IHME
1.62 (1.53 - 1.69) 2002 Modelled IHME
1.63 (1.54 - 1.70) 2001 Modelled IHME
1.65 (1.55 - 1.72) 2000 Modelled IHME
1.66 (1.57 - 1.73) 1999 Modelled IHME
1.66 (1.58 - 1.74) 1998 Modelled IHME
1.67 (1.59 - 1.74) 1997 Modelled IHME
1.68 (1.60 - 1.75) 1996 Modelled IHME
1.69 (1.60 - 1.76) 1995 Modelled IHME
1.7 (1.62 - 1.77) 1994 Modelled IHME
1.71 (1.63 - 1.78) 1993 Modelled IHME
1.72 (1.64 - 1.79) 1992 Modelled IHME
1.73 (1.65 - 1.81) 1991 Modelled IHME
1.75 (1.65 - 1.83) 1990 Modelled IHME
0.8 (0.70 - 0.90) 2010 Survey/reported Ramiere, 2016
0.7 (0.50 - 0.90) 2004 Survey/reported Meffre C , 2010
0.02 (0.02 - 0.03) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.07 (0.05 - 0.09) 2019 Modelled IHME
0.07 (0.06 - 0.09) 2018 Modelled IHME
0.08 (0.06 - 0.10) 2017 Modelled IHME
0.09 (0.07 - 0.11) 2016 Modelled IHME
0.1 (0.08 - 0.12) 2015 Modelled IHME
0.12 (0.09 - 0.14) 2014 Modelled IHME
0.14 (0.11 - 0.17) 2013 Modelled IHME
0.16 (0.13 - 0.20) 2012 Modelled IHME
0.19 (0.15 - 0.24) 2011 Modelled IHME
0.22 (0.17 - 0.27) 2010 Modelled IHME
0.24 (0.19 - 0.30) 2009 Modelled IHME
0.28 (0.22 - 0.34) 2008 Modelled IHME
0.31 (0.24 - 0.38) 2007 Modelled IHME
0.33 (0.26 - 0.42) 2006 Modelled IHME
0.36 (0.27 - 0.45) 2005 Modelled IHME
0.37 (0.29 - 0.47) 2004 Modelled IHME
0.39 (0.30 - 0.49) 2003 Modelled IHME
0.4 (0.32 - 0.51) 2002 Modelled IHME
0.42 (0.32 - 0.53) 2001 Modelled IHME
0.43 (0.33 - 0.55) 2000 Modelled IHME
0.44 (0.34 - 0.56) 1999 Modelled IHME
0.45 (0.36 - 0.56) 1998 Modelled IHME
0.46 (0.37 - 0.57) 1997 Modelled IHME
0.48 (0.37 - 0.59) 1996 Modelled IHME
0.49 (0.38 - 0.60) 1995 Modelled IHME
0.51 (0.41 - 0.62) 1994 Modelled IHME
0.54 (0.43 - 0.65) 1993 Modelled IHME
0.56 (0.45 - 0.68) 1992 Modelled IHME
0.59 (0.47 - 0.72) 1991 Modelled IHME
0.62 (0.49 - 0.77) 1990 Modelled IHME
0.01 (0.01 - 0.01) 2015 Modelled WHO
Showing out of
Show more
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
1.4 (0.70 - 2.40) 2009 Survey/reported Sauvage C et al , 2015
Pregnant women
Download
Value (%) Year Type Source
0.8 (0.60 - 0.70) 2011 Survey/reported Richaud-Eyraud E et al, 2015
Prisoners
Download
Value (%) Year Type Source
0.6 (0.10 - 2.10) 2013 Survey/reported Corinne B et al, 2015.

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
2.64 (1.98 - 3.41) 2019 Modelled IHME
2.68 (2.03 - 3.47) 2018 Modelled IHME
2.74 (2.08 - 3.52) 2017 Modelled IHME
2.76 (2.10 - 3.55) 2016 Modelled IHME
2.86 (2.20 - 3.67) 2015 Modelled IHME
2.84 (2.19 - 3.64) 2014 Modelled IHME
2.91 (2.26 - 3.73) 2013 Modelled IHME
2.97 (2.30 - 3.80) 2012 Modelled IHME
3.01 (2.34 - 3.83) 2011 Modelled IHME
3.06 (2.37 - 3.90) 2010 Modelled IHME
3.09 (2.39 - 3.90) 2009 Modelled IHME
3.1 (2.40 - 3.92) 2008 Modelled IHME
3.12 (2.41 - 3.94) 2007 Modelled IHME
3.16 (2.44 - 4.01) 2006 Modelled IHME
3.22 (2.48 - 4.08) 2005 Modelled IHME
3.28 (2.53 - 4.16) 2004 Modelled IHME
3.46 (2.65 - 4.38) 2003 Modelled IHME
3.54 (2.71 - 4.49) 2002 Modelled IHME
3.6 (2.76 - 4.57) 2001 Modelled IHME
3.65 (2.80 - 4.63) 2000 Modelled IHME
3.72 (2.87 - 4.74) 1999 Modelled IHME
3.73 (2.88 - 4.76) 1998 Modelled IHME
3.68 (2.84 - 4.70) 1997 Modelled IHME
3.67 (2.83 - 4.62) 1996 Modelled IHME
3.62 (2.80 - 4.56) 1995 Modelled IHME
3.58 (2.75 - 4.54) 1994 Modelled IHME
3.54 (2.72 - 4.51) 1993 Modelled IHME
3.5 (2.68 - 4.50) 1992 Modelled IHME
3.5 (2.66 - 4.52) 1991 Modelled IHME
3.52 (2.66 - 4.54) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
1,750 (1,314 - 2,259) 2019 Modelled IHME
1,770 (1,341 - 2,288) 2018 Modelled IHME
1,802 (1,371 - 2,316) 2017 Modelled IHME
1,808 (1,377 - 2,331) 2016 Modelled IHME
1,867 (1,435 - 2,401) 2015 Modelled IHME
1,850 (1,428 - 2,367) 2014 Modelled IHME
1,886 (1,460 - 2,413) 2013 Modelled IHME
1,916 (1,482 - 2,446) 2012 Modelled IHME
1,932 (1,499 - 2,458) 2011 Modelled IHME
1,952 (1,512 - 2,488) 2010 Modelled IHME
1,959 (1,516 - 2,476) 2009 Modelled IHME
1,959 (1,518 - 2,476) 2008 Modelled IHME
1,956 (1,513 - 2,474) 2007 Modelled IHME
1,969 (1,521 - 2,500) 2006 Modelled IHME
1,993 (1,534 - 2,527) 2005 Modelled IHME
2,016 (1,559 - 2,557) 2004 Modelled IHME
2,112 (1,622 - 2,679) 2003 Modelled IHME
2,150 (1,646 - 2,724) 2002 Modelled IHME
2,174 (1,667 - 2,756) 2001 Modelled IHME
2,186 (1,677 - 2,775) 2000 Modelled IHME
2,219 (1,711 - 2,827) 1999 Modelled IHME
2,215 (1,710 - 2,821) 1998 Modelled IHME
2,171 (1,677 - 2,778) 1997 Modelled IHME
2,158 (1,665 - 2,719) 1996 Modelled IHME
2,125 (1,643 - 2,677) 1995 Modelled IHME
2,093 (1,608 - 2,655) 1994 Modelled IHME
2,067 (1,589 - 2,632) 1993 Modelled IHME
2,035 (1,556 - 2,619) 1992 Modelled IHME
2,029 (1,544 - 2,624) 1991 Modelled IHME
2,031 (1,536 - 2,625) 1990 Modelled IHME
3,845 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
12 (8 - 17) 2019 Modelled IHME
12 (8 - 17) 2018 Modelled IHME
12 (8 - 17) 2017 Modelled IHME
12 (8 - 17) 2016 Modelled IHME
12 (8 - 17) 2015 Modelled IHME
12 (8 - 17) 2014 Modelled IHME
12 (8 - 17) 2013 Modelled IHME
12 (8 - 17) 2012 Modelled IHME
12 (8 - 17) 2011 Modelled IHME
12 (8 - 17) 2010 Modelled IHME
12 (8 - 17) 2009 Modelled IHME
12 (9 - 17) 2008 Modelled IHME
12 (9 - 17) 2007 Modelled IHME
12 (9 - 18) 2006 Modelled IHME
12 (9 - 18) 2005 Modelled IHME
12 (9 - 18) 2004 Modelled IHME
12 (9 - 18) 2003 Modelled IHME
12 (9 - 18) 2002 Modelled IHME
13 (9 - 18) 2001 Modelled IHME
13 (9 - 18) 2000 Modelled IHME
13 (9 - 18) 1999 Modelled IHME
13 (9 - 18) 1998 Modelled IHME
13 (9 - 18) 1997 Modelled IHME
13 (9 - 18) 1996 Modelled IHME
13 (9 - 19) 1995 Modelled IHME
13 (9 - 19) 1994 Modelled IHME
13 (9 - 19) 1993 Modelled IHME
13 (9 - 19) 1992 Modelled IHME
13 (9 - 19) 1991 Modelled IHME
13 (9 - 19) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
90 2018 Survey/reported WHO/UNICEF
90 2017 Survey/reported WHO/UNICEF
90 2016 Survey/reported WHO/UNICEF
88 2015 Survey/reported WHO/UNICEF
83 2014 Survey/reported WHO/UNICEF
82 2013 Survey/reported WHO/UNICEF
78 2012 Survey/reported WHO/UNICEF
74 2011 Survey/reported WHO/UNICEF
64 2010 Survey/reported WHO/UNICEF
51 2009 Survey/reported WHO/UNICEF
47 2008 Survey/reported WHO/UNICEF
42 2007 Survey/reported WHO/UNICEF
39 2006 Survey/reported WHO/UNICEF
35 2005 Survey/reported WHO/UNICEF
35 2004 Survey/reported WHO/UNICEF
28 2003 Survey/reported WHO/UNICEF
29 2002 Survey/reported WHO/UNICEF
28 2001 Survey/reported WHO/UNICEF
26 2000 Survey/reported WHO/UNICEF
24 1999 Survey/reported WHO/UNICEF
27 1998 Survey/reported WHO/UNICEF
Showing out of
Show more

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
109 2015 Survey/reported EMCDDA, 2019
150 (127 - 186) 2014 Survey/reported EMCDDA, 2017
Showing out of
Show more

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
85 2017 Survey/reported EMCDDA, 2019
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes (for risk groups)
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
% of substance use disorder facilities offering hepatitis treatment
Many (31-60%)

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.85 (0.70 - 1.04) 2019 Modelled IHME
0.85 (0.69 - 1.03) 2018 Modelled IHME
0.84 (0.69 - 1.03) 2017 Modelled IHME
0.84 (0.69 - 1.02) 2016 Modelled IHME
0.84 (0.68 - 1.03) 2015 Modelled IHME
0.84 (0.68 - 1.03) 2014 Modelled IHME
0.84 (0.68 - 1.03) 2013 Modelled IHME
0.84 (0.69 - 1.03) 2012 Modelled IHME
0.84 (0.69 - 1.03) 2011 Modelled IHME
0.84 (0.69 - 1.04) 2010 Modelled IHME
0.83 (0.68 - 1.01) 2009 Modelled IHME
0.8 (0.65 - 0.96) 2008 Modelled IHME
0.75 (0.62 - 0.90) 2007 Modelled IHME
0.71 (0.59 - 0.85) 2006 Modelled IHME
0.69 (0.57 - 0.83) 2005 Modelled IHME
0.68 (0.57 - 0.82) 2004 Modelled IHME
0.67 (0.56 - 0.81) 2003 Modelled IHME
0.67 (0.56 - 0.80) 2002 Modelled IHME
0.66 (0.55 - 0.80) 2001 Modelled IHME
0.66 (0.55 - 0.80) 2000 Modelled IHME
0.67 (0.56 - 0.81) 1999 Modelled IHME
0.68 (0.57 - 0.83) 1998 Modelled IHME
0.7 (0.58 - 0.86) 1997 Modelled IHME
0.72 (0.59 - 0.88) 1996 Modelled IHME
0.74 (0.60 - 0.89) 1995 Modelled IHME
0.74 (0.61 - 0.90) 1994 Modelled IHME
0.75 (0.62 - 0.90) 1993 Modelled IHME
0.75 (0.62 - 0.91) 1992 Modelled IHME
0.75 (0.62 - 0.91) 1991 Modelled IHME
0.76 (0.62 - 0.92) 1990 Modelled IHME
Showing out of
Show more

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
1 (0.90 - 1.20) 2010 Survey/reported Ramiere, 2016
0.84 (0.65 - 1.10) 2004 Survey/reported Meffre C et al, 2010
0.6 (0.40 - 1.10) 2014 Modelled Gower et al, 2014
Showing out of
Show more
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
1 (0.50 - 1.90) 2009 Survey/reported Sauvage C et al , 2015
People who inject drugs (PWID)
Download
Value (%) Year Type Source
62.2 (59.40 - 64.90) 2011 Survey/reported Weill-Barillet L et al, 2016
Prisoners
Download
Value (%) Year Type Source
6.3 (6.10 - 6.50) 2016 Modelled ECDC

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
8.09 (6.60 - 9.63) 2019 Modelled IHME
8.11 (6.62 - 9.64) 2018 Modelled IHME
8.15 (6.63 - 9.73) 2017 Modelled IHME
8.06 (6.56 - 9.60) 2016 Modelled IHME
8.17 (6.60 - 9.74) 2015 Modelled IHME
8.04 (6.51 - 9.53) 2014 Modelled IHME
8.12 (6.66 - 9.64) 2013 Modelled IHME
8.16 (6.68 - 9.77) 2012 Modelled IHME
8.14 (6.65 - 9.77) 2011 Modelled IHME
8.11 (6.62 - 9.74) 2010 Modelled IHME
8.03 (6.57 - 9.68) 2009 Modelled IHME
7.93 (6.47 - 9.58) 2008 Modelled IHME
7.79 (6.40 - 9.41) 2007 Modelled IHME
7.72 (6.33 - 9.35) 2006 Modelled IHME
7.71 (6.29 - 9.34) 2005 Modelled IHME
7.68 (6.28 - 9.31) 2004 Modelled IHME
7.86 (6.50 - 9.54) 2003 Modelled IHME
7.85 (6.44 - 9.54) 2002 Modelled IHME
7.82 (6.40 - 9.52) 2001 Modelled IHME
7.83 (6.40 - 9.50) 2000 Modelled IHME
7.97 (6.52 - 9.69) 1999 Modelled IHME
7.92 (6.45 - 9.69) 1998 Modelled IHME
7.75 (6.28 - 9.49) 1997 Modelled IHME
7.66 (6.18 - 9.36) 1996 Modelled IHME
7.48 (6.02 - 9.11) 1995 Modelled IHME
7.31 (5.88 - 8.87) 1994 Modelled IHME
7.11 (5.73 - 8.65) 1993 Modelled IHME
6.92 (5.58 - 8.46) 1992 Modelled IHME
6.82 (5.50 - 8.38) 1991 Modelled IHME
6.75 (5.42 - 8.34) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
5,356 (4,369 - 6,375) 2019 Modelled IHME
5,353 (4,373 - 6,365) 2018 Modelled IHME
5,367 (4,363 - 6,406) 2017 Modelled IHME
5,287 (4,304 - 6,294) 2016 Modelled IHME
5,340 (4,315 - 6,367) 2015 Modelled IHME
5,228 (4,237 - 6,199) 2014 Modelled IHME
5,260 (4,314 - 6,244) 2013 Modelled IHME
5,261 (4,306 - 6,293) 2012 Modelled IHME
5,221 (4,261 - 6,265) 2011 Modelled IHME
5,175 (4,225 - 6,216) 2010 Modelled IHME
5,096 (4,168 - 6,144) 2009 Modelled IHME
5,008 (4,087 - 6,051) 2008 Modelled IHME
4,890 (4,019 - 5,906) 2007 Modelled IHME
4,814 (3,950 - 5,833) 2006 Modelled IHME
4,777 (3,895 - 5,783) 2005 Modelled IHME
4,726 (3,865 - 5,731) 2004 Modelled IHME
4,804 (3,972 - 5,830) 2003 Modelled IHME
4,764 (3,910 - 5,790) 2002 Modelled IHME
4,715 (3,861 - 5,741) 2001 Modelled IHME
4,692 (3,835 - 5,696) 2000 Modelled IHME
4,748 (3,883 - 5,773) 1999 Modelled IHME
4,695 (3,828 - 5,749) 1998 Modelled IHME
4,580 (3,711 - 5,604) 1997 Modelled IHME
4,506 (3,636 - 5,506) 1996 Modelled IHME
4,385 (3,528 - 5,343) 1995 Modelled IHME
4,275 (3,440 - 5,189) 1994 Modelled IHME
4,147 (3,340 - 5,045) 1993 Modelled IHME
4,026 (3,246 - 4,923) 1992 Modelled IHME
3,954 (3,188 - 4,857) 1991 Modelled IHME
3,901 (3,132 - 4,820) 1990 Modelled IHME
4,917 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
45 (35 - 55) 2019 Modelled IHME
46 (36 - 55) 2018 Modelled IHME
46 (36 - 56) 2017 Modelled IHME
46 (36 - 55) 2016 Modelled IHME
46 (36 - 56) 2015 Modelled IHME
46 (36 - 55) 2014 Modelled IHME
45 (36 - 55) 2013 Modelled IHME
45 (36 - 55) 2012 Modelled IHME
45 (36 - 55) 2011 Modelled IHME
45 (35 - 55) 2010 Modelled IHME
45 (35 - 55) 2009 Modelled IHME
45 (35 - 55) 2008 Modelled IHME
44 (34 - 54) 2007 Modelled IHME
44 (34 - 54) 2006 Modelled IHME
44 (33 - 54) 2005 Modelled IHME
43 (33 - 54) 2004 Modelled IHME
43 (33 - 53) 2003 Modelled IHME
43 (32 - 53) 2002 Modelled IHME
42 (32 - 53) 2001 Modelled IHME
42 (32 - 53) 2000 Modelled IHME
42 (32 - 52) 1999 Modelled IHME
42 (32 - 52) 1998 Modelled IHME
42 (32 - 52) 1997 Modelled IHME
42 (31 - 52) 1996 Modelled IHME
42 (31 - 52) 1995 Modelled IHME
41 (31 - 52) 1994 Modelled IHME
41 (31 - 52) 1993 Modelled IHME
41 (31 - 51) 1992 Modelled IHME
40 (31 - 51) 1991 Modelled IHME
40 (30 - 51) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
109 2015 Survey/reported EMCDDA, 2019
150 (127 - 186) 2014 Survey/reported EMCDDA, 2017
Showing out of
Show more

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
85 2017 Survey/reported EMCDDA, 2019
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes (for risk groups)
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
% of substance use disorder facilities offering hepatitis treatment
Many (31-60%)

Overview

HBV elimination goal
HCV elimination goal

Hepatitis related deaths (national)

Modelled

HBV
1,750
2019
(1,314 - 2,259)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
5,356
2019
(4,369 - 6,375)
IHME

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
109
2015
EMCDDA, 2019
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Resources